Enzyme-activated nanomaterials for MR imaging and tumor therapy

Lv, Jingxia; Yue, Renye; Liu, Huiyi; Du, Huan; Lu, Chang; Zhang, Cheng; Guan, Guoqiang; Min, Sunhong; Huan, Shuangyan; Kang, Heemin; Song, Guosheng

doi:10.1016/j.ccr.2024.215842

Coordination Chemistry Reviews

2024

DOI: 10.1016/j.ccr.2024.215842

|View full text |Cite

Enzyme-activated nanomaterials for MR imaging and tumor therapy

Jingxia Lv,

Renye Yue,

Huiyi Liu

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

References 227 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Recent advances of nanomaterials in imaging liver fibrosis

Cui,

Zhang,

et al. 2024

BMEMat

View full text Add to dashboard Cite

Liver fibrosis is a pathological process resulting from prolonged exposure to various injury factors. It is characterized by the abnormal proliferation and activation of hepatic stellate cells and excessive deposition of extracellular matrix. If left untreated, it can progress to cirrhosis, liver failure, and even liver cancer. There is currently no efficient and accurate clinical diagnostic method for early liver fibrosis. Therefore, there is an urgent need to address the challenge of accurate staging and early diagnosis of liver fibrosis in clinical practice. Recently, nanomaterials have demonstrated significant potential for enhancing the diagnosis of liver fibrosis. Nanomaterials possess the ability to precisely identify and target the microenvironment associated with liver fibrosis. By enhancing their enrichment in the target area, nanomaterials can improve imaging contrast of fibrosis lesions in the liver, thereby enabling accurate diagnosis of liver fibrosis. Accordingly, this review delves into the latest research and advancements concerning nanomaterials in liver fibrosis diagnosis.

show abstract

Recent advances of nanomaterials in imaging liver fibrosis

Cui,

Zhang,

et al. 2024

BMEMat

View full text Add to dashboard Cite

show abstract

Nanostructures and nanoparticles as medical diagnostic imaging contrast agents: A review

Mhlanga,

Mphuthi,

Van der Walt

et al. 2024

Materials Today Chemistry

View full text Add to dashboard Cite

Nanozyme-based cancer theranostics: A scientometric analysis and comprehensive review

Xing,

Yasinjan,

Sun

et al. 2024

Nano Today

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Enzyme-activated nanomaterials for MR imaging and tumor therapy

Cited by 6 publications

References 227 publications

Recent advances of nanomaterials in imaging liver fibrosis

Recent advances of nanomaterials in imaging liver fibrosis

Nanostructures and nanoparticles as medical diagnostic imaging contrast agents: A review

Nanozyme-based cancer theranostics: A scientometric analysis and comprehensive review

Contact Info

Product

Resources

About